China SXT Pharmaceuticals (SXTC) Notes Payables (2018 - 2025)
China SXT Pharmaceuticals (SXTC) recorded quarterly Notes Payables of $976367.0 in Q3 2025, up 39.05% quarter-over-quarter from $702184.0 in Q1 2025, and up 17.93% on a YoY basis from $827918.0 in Q3 2024.
China SXT Pharmaceuticals (SXTC) Notes Payables (2018 - 2025) Analysis & Trends
China SXT Pharmaceuticals' Notes Payables history runs 7 years deep, the most recent figure standing at $976367.0 for Q3 2025.
- In Q3 2025, Notes Payables rose 17.93% year-over-year to $976367.0; the TTM figure through Sep 2025 stood at $976367.0 (up 17.93% YoY), while the FY2025 annual figure was $702184.0, up 42.42% from the prior year.
- Notes Payables was $976367.0 for Q3 2025 at China SXT Pharmaceuticals, up from $702184.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $976367.0 in Q3 2025 to a low of $24042.0 in Q3 2021.
- Historically, Notes Payables has averaged $436926.2 across 4 years, with a median of $380162.0 in 2023.
- The sharpest annual moves came in 2021 and 2024: Notes Payables slumped 47.46% in 2021, then surged 209.77% in 2024.
- A 4-year view of Notes Payables shows it stood at $24042.0 in 2021, then soared by 1011.68% to $267270.0 in 2023, then soared by 209.77% to $827918.0 in 2024, then gained by 17.93% to $976367.0 in 2025.
- The last three Notes Payables figures came in at $976367.0 (Q3 2025), $702184.0 (Q1 2025), and $827918.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | China SXT Pharmaceuticals | 187.96 Mn | 166.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 976,367.00 |
| Mar 31, 2025 | 702,184.00 |
| Sep 30, 2024 | 827,918.00 |
| Mar 31, 2024 | 493,054.00 |
| Sep 30, 2023 | 267,270.00 |
| Mar 31, 2023 | 167,453.00 |
| Sep 30, 2021 | 24,042.00 |
| Mar 31, 2021 | 37,122.00 |
| Sep 30, 2020 | 45,757.00 |
| Mar 31, 2020 | 43,902.00 |
| Sep 30, 2019 | 62,533.00 |
| Mar 31, 2019 | 233,336.00 |
| Sep 30, 2018 | -166,236.00 |
| Mar 31, 2018 | 385,121.00 |